In this study, we investigated the mechanism of CDK4/6 inhibitor resistance and variation after CDK4/6 inhibitor resistance using breast cancer cell lines, hormone-resistant cell lines, and two different kinds of CDK4/6 inhibitor resistance cell lines. The gene discussed is CDK4; the disease is breast carcinoma.